LY-334,370

LY-334,370

LY-334,370
Identifiers
CAS number 182563-08-2
PubChem 5311258
IUPHAR ligand 20
Jmol-3D images Image 1
Properties
Molecular formula C21H22FN3O
Molar mass 351.42 g/mol
 YesY (verify) (what is: YesY/N?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

LY-334,370 is a selective 5-HT1F receptor agonist[1] which was under development by Eli Lilly and Company for the treatment of migraine headaches.[2] The drug showed efficacy in a phase II clinical trial[3] but further development was halted due to toxicity detected in animals.[4]

See also

  • Lasmiditan, another 5-HT1F agonist for the treatment of migraine

References

External links

  • Medical Subject Headings (MeSH)